PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'School of Pharmaceutical Sciences and Medical Technology, Putian University, Putian 351100, China.\', \'Department of Internal Medicine, Kaohsiung Veterans General Hospital, Tainan Branch, Tainan, Taiwan.\', \'Department of Pharmacy, Chi Mei Medical Center, Liouying, Taiwan.\', \'Yijia Pharmacy, Tainan 70846, Taiwan.\', \'School of Management, Putian University, Putian 351100, China.\', \'Department of Laboratory Medicine, National Taiwan University Hospital, National Taiwan University College of Medicine, Taipei, Taiwan; Department of Internal Medicine, National Taiwan University Hospital, National Taiwan University College of Medicine, Taipei, Taiwan. Electronic address: hsporen@ntu.edu.tw.\']
?:citedBy
  • -1
?:creator
?:doi
  • S0924-8579(20)30286-710.1016/j.ijantimicag.2020.106103
?:doi
?:hasPublicationType
?:journal
  • International journal of antimicrobial agents
is ?:pmid of
?:pmid
?:pmid
  • 32712333
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.699
?:rankingScore_hIndex
  • 107
?:title
  • Tocilizumab for severe COVID-19: a systematic review and meta-analysis.
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all